Literature DB >> 26781064

A double-negative feedback loop between EZH2 and miR-26a regulates tumor cell growth in hepatocellular carcinoma.

Chunbo Zhuang1, Pei Wang2, Da Huang1, Luming Xu3, Xiaobei Wang1, Lin Wang1, Lihua Hu1.   

Abstract

Accumulating evidence demonstrates the important roles of microRNAs (miRNAs) in tumor development and progression. miR-26a has been reported to be downregulated in several types of cancers including hepatocellular carcinoma, but the underlying mechanism of how miR-26a is repressed remains largely unknown. In the present study, we performed western blot analysis, qRT-PCR, luciferase reporter assay and chromatin immunoprecipitation assay to investigate the relationship between miR-26a and the enhancer of zest homologue 2 (EZH2). CCK-8 assay and colony formation assay were carried out to explore the effect of miR-26a on HCC cells proliferation. We demonstrated that miR-26a was epigenetically repressed by EZH2-mediated H3K27 trimethylation within the miR-26a promoter. Moreover, we confirmed that EZH2 was also a direct target of miR-26a in HCC cells, thus, creating a double-negative feedback loop. Furthermore, miR-26a restoration increased the expressions of its host genes (CTDSPL and CTDSP2). Overexpression of EZH2 abrogated miR-26a induction of CTDSPL and CTDSP2. Restoring the balance of the double-negative feedback loop by miR-26a overpression or EZH2 silence significantly inhibited HCC cell growth. Overexpression of EZH2 rescued the growth inhibition effect of miR-26a. These findings suggest that an imbalanced double-negative feedback loop between EZH2 and miR-26a exists in HCC cells, which contributes to miR-26a deregulation and regulates tumor cells proliferation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26781064     DOI: 10.3892/ijo.2016.3336

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

1.  ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway.

Authors:  Nuozhou Wang; Ming-Yue Li; Yi Liu; Jianqing Yu; Jianwei Ren; Zhiyuan Zheng; Shanshan Wang; Shucai Yang; Sheng-Li Yang; Li-Ping Liu; Bao-Guang Hu; Charing Cn Chong; Juanita L Merchant; Paul Bs Lai; George Gong Chen
Journal:  Cancer Lett       Date:  2019-12-23       Impact factor: 8.679

2.  The protective effects of microRNA-26a in steroid-induced osteonecrosis of the femoral head by repressing EZH2.

Authors:  Gang Li; Haifeng Liu; Xiaogang Zhang; Xingchao Liu; Guodong Zhang; Qinghe Liu
Journal:  Cell Cycle       Date:  2020-02-13       Impact factor: 4.534

3.  Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer.

Authors:  Yang Yi; Yanqiang Li; Chao Li; Longxiang Wu; Dongyu Zhao; Fuxi Li; Ladan Fazli; Rui Wang; Long Wang; Xuesen Dong; Wei Zhao; Kaifu Chen; Qi Cao
Journal:  Oncogene       Date:  2022-01-29       Impact factor: 8.756

Review 4.  Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.

Authors:  Anthos Christofides; Theodoros Karantanos; Kankana Bardhan; Vassiliki A Boussiotis
Journal:  Oncotarget       Date:  2016-12-20

5.  EZH2 overexpression is associated with poor prognosis in patients with glioma.

Authors:  Yanyang Zhang; Xinguang Yu; Ling Chen; Zhibin Zhang; Shiyu Feng
Journal:  Oncotarget       Date:  2017-01-03

6.  High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors.

Authors:  Ning Zhang; Zhi Zeng; Shaobo Li; Fei Wang; Peng Huang
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

7.  Comparison of the Transcriptomes and Proteomes of Serum Exosomes from Marek's Disease Virus-Vaccinated and Protected and Lymphoma-Bearing Chickens.

Authors:  Sabari Nath Neerukonda; Phaedra Tavlarides-Hontz; Fiona McCarthy; Kenneth Pendarvis; Mark S Parcells
Journal:  Genes (Basel)       Date:  2019-02-05       Impact factor: 4.096

8.  EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200c.

Authors:  Leibo Xu; Junlong Lin; Wanyu Deng; Weixin Luo; Yipei Huang; Chao-Qun Liu; Fa-Peng Zhang; Yu-Fei Qin; Ping-Pui Wong; Chao Liu
Journal:  Oncogenesis       Date:  2020-11-09       Impact factor: 7.485

Review 9.  Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma.

Authors:  Lisa Linck-Paulus; Claus Hellerbrand; Anja K Bosserhoff; Peter Dietrich
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

10.  Trio-based genome sequencing identifies candidate causal genes in lifelong premature ejaculation.

Authors:  Dao-Qi Wang; Yang-Tian Jiao; Le Ling; Jia-Xin Wang; Yong-Hua Niu; Zhe Tang; Yin-Wei Chen; Jia-Nan Gong; Tao Wang; Ji-Hong Liu; Qing Ling
Journal:  Asian J Androl       Date:  2021 May-Jun       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.